ONE MAN CAN AND WILL FIND A WAY, WHY NOT BE THAT MAN...

News

LATEST NEWS

ALS Patients Connected meeting

In January, the first successful mutual meeting between biotech company Treeway and patient organization ‘ALS Patients Connected’ was organized. Treeway is initiated ‘by patients and for patients’ and this meeting – where we entered into a conversation with one another – is an important
Continue Reading →

Treeway is looking for a Post-doc to support extensive bio-informatic analysis

Post-doc position for 3 years In collaboration with the University Medical Center Utrecht, Treeway is looking for an enthousiastic post-doc who will be supporting extensive bio-informatic analysis of the genetic data obtained within Project MinE. Project MinE (http://www.projectmine.com/) is the wor
Continue Reading →

Treeway present at ALS Association’s Drug Discovery and Development Workshop 2016

Inez de Greef and Ronald van der Geest were invited to the Drug Discovery and Development Workshop in Florida from 7 to 9 October, organized by the ALS Association. The progress of the second product of Treeway, TW002, will be presented. TW002 is a gene therapy whereby GDNF is delivered with the vir
Continue Reading →

Verklaring naar aanleiding van artikel ‘Heel de wereld kijkt naar Katwijk’ gepubliceerd op 23 juli 2016 in De Volkskrant

In het artikel ‘Heel de wereld kijkt naar Katwijk’ beschrijft Jan Fens zijn zoektocht naar een medicijn tegen zijn ziekte Hereditary Cerebral Haemorrhages with Amyloidosis – Dutch type (HCHWA-D), beter bekend als de Katwijkse Ziekte. Uit dit artikel zou ten onrechte kunnen worden afgeleid dat Treewa
Continue Reading →

Great interview in FD from Treeway’s founder Bernard Muller and CEO Inez

Our Founder Bernard Muller and CEO Inez de Greef were interviewed by the FD about Treeway’s mission and ambition. For full article click here.
Continue Reading →

Oproep aan ALS-patiënten!

Bent u ALS-patiënt en wilt u ons helpen onderzoeken hoe we medicatie voor Treeway zo gebruikersvriendelijk mogelijk kunnen ontwikkelen? Vul dan onderstaande patiënten enquete in. Dank u wel voor medewerking! https://nl.surveymonkey.com/r/9SJCML6  
Continue Reading →

Pioneering, entrepreneurship and ALS

Great interview with PharmaTelevision and Bernard Muller Bernard discusses his criteria for entrepreneurship, and how he has turned this into a personal fight against ALS. http://www.pharmatelevision.com/Video/1434-PTVNRBernardMuller.aspx
Continue Reading →

Donate now! Tour du ALS 2016

Treeway supports Tour du ALS 2016! This year, on June 3rd, our colleagues Ronald and Dirk will climb the famous Mont Ventoux mountain by bike. Will you help our team Treeway Riders to increase awareness and speed up therapy development for ALS? Donate now! http://deelnemers.tourduals.nl/team/147 &nb
Continue Reading →

ALS Data Challenge organized by Accenture great success!

We thank Accenture Digital for organizing the ALS hackathon. It was a very good organized and inspiring day with a lot of enthusiasm! Clusters of patients with similar disease progression have been identified in advance. While during the event, the participating teams were asked to predict these clu
Continue Reading →

Treeway Summer Challenge will be postponed to 2017

Treeway believes in the potential of young talent and therefore we have invested time and energy in organizing the Treeway Summer Challenge. This initiative gives students the opportunity to grow, develop and with their knowledge contribute to the search for a solution for the deadly Motor Neuron Di
Continue Reading →

Donderdag 24-02-2016: Holland Bio Orphan Café met o.a. Bernard Muller

Tijdens het Orphan Café op 24 maart a.s. wordt er ingegaan op de stem van patiënten in geneesmiddelenontwikkeling. Bernard Muller zal in aanwezigheid met o.a. patiëntenorganisaties, gezondheidsfondsen en bedrijven ingaan op vragen hoe patiënten en patiëntenorganisaties een belangrijke bron van kenni
Continue Reading →

Inez de Greef joined the Scientific Advisory Board of the ALS Research Forum

Inez de Greef joined the Scientific Advisory Board of the ALS Research Form. The mission of the ALS Research Forum is to accelerate development of new therapies for amyotrophic lateral sclerosis (ALS, a.k.a. Lou Gehrig’s disease), by providing a reputable and valued open-access forum for high qualit
Continue Reading →

Back to top